No photo of Gary E Schiltz

View Scopus Profile

Gary E Schiltz

  • 477 Citations
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gary E Schiltz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

CardioExcyte 96 System for Pharmacology Research at Northwestern University

Abdulkadir, S. A., Ardehali, H., Arora, R. K., Burridge, P., George Jr, A. L., Kearney, J. A., McNally, E. M., Schiltz, G. E., Silverman, R. B., Watterson, D. M. & Wilsbacher, L. D.

National Institutes of Health

6/15/20 → 6/14/21

Project: Research project

    • Development of Novel MNK Inhibitors for Treating Glioblastoma

    Clutter, M., Eckerdt, F. D., Horbinski, C. M., James, C. D., Mishra, R. K., Platanias, L. C. & Schiltz, G. E.

    National Institute of Neurological Disorders and Stroke

    9/1/19 → 6/30/24

    Project: Research project

    • Schiltz Lab - Development of Novel MNK Inhibitors for Treating Glioblastoma

    Schiltz, G. E.

    National Institute of Neurological Disorders and Stroke

    9/1/19 → 6/30/24

    Project: Research project

    • DART2.0: comprehensive cell type-specific behavioral neuropharmacology

    Schiltz, G. E.

    Duke University, National Institute of Mental Health

    9/14/18 → 9/13/21

    Project: Research project

    • Subproject for SP0046885 Luo Core B

    Jin, J., Kandela, I., Luo, X., Mathew, J., Schiltz, G. E., Scott, E. A., Vanoye, C. G. & Wertheim, J. A.

    National Institute of Diabetes, Digestive and Kidney Diseases

    8/1/18 → 7/31/23

    Project: Research project

    • Research Output

    • 477 Citations
    • 25 Article
    • 2 Review article
    • 1 Chapter

    A novel strategy to block mitotic progression for targeted therapy

    Chi, J. J., Li, H., Zhou, Z., Izquierdo-Ferrer, J., Xue, Y., Wavelet, C. M., Schiltz, G. E., Zhang, B., Cristofanilli, M., Lu, X., Bahar, I. & Wan, Y., Nov 2019, In : EBioMedicine. 49, p. 40-54 15 p.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands

    Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., Jul 3 2019, In : ChemMedChem. 14, 13, p. 1248-1256 9 p.

    Research output: Contribution to journal › Article

    • Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands

    Iyamu, I. D., Lv, W., Malik, N., Mishra, R. K. & Schiltz, G. E., May 1 2019, In : Bioorganic and Medicinal Chemistry. 27, 9, p. 1824-1835 12 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Discovery of novel Mnk inhibitors using mutation-based induced-fit virtual high-throughput screening

    Mishra, R. K., Clutter, M. R., Blyth, G. T., Kosciuczuk, E. M., Blackburn, A. Z., Beauchamp, E. M., Schiltz, G. E. & Platanias, L. C., Oct 1 2019, In : Chemical Biology and Drug Design. 94, 4, p. 1813-1823 11 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges

    Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.

    Research output: Contribution to journal › Article

    • 1 Scopus citations